Table 2.
Part | Liver metastases | Bone metastases | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
N | Type | 18F-FDG | 68Ga-DOTA-SSAs | Wilcoxon P | N | Type | 18F-FDG | 68Ga-DOTA-SSAs | Wilcoxon P | |
Total | 69 | SUVT/B | 2.29 ± 1.48 | 4.92 ± 4.50 | ≤0.001 | 74 | SUVT/B | 3.03 ± 2.64 | 25.70 ± 24.26 | ≤0.001 |
Amount | 10.67 ± 23.05 | 21.53 ± 31.41 | 0.010 | Amount | 9.81 ± 22.89 | 25.91 ± 36.87 | ≤0.001 | |||
G1 + G2 | 48 | SUVT/B | 1.70 ± 0.78 | 6.11 ± 4.83 | ≤0.001 | 50 | SUVT/B | 2.04 ± 1.33 | 30.29 ± 25.90 | ≤0.001 |
Amount | 5.44 ± 14.50 | 22.77 ± 30.53 | ≤0.001 | Amount | 7.36 ± 20.24 | 25.62 ± 36.39 | ≤0.001 | |||
G3 | 11 | SUVT/B | 3.45 ± 2.17 | 2.31 ± 2.34 | 0.110 | 12 | SUVT/B | 4.32 ± 2.95 | 16.88 ± 15.75 | 0.049 |
Amount | 17.00 ± 28.79 | 16.64 ± 29.22 | 0.722 | Amount | 13.75 ± 28.50 | 24.50 ± 37.10 | 0.026 | |||
NEC | 10 | SUVT/B | 3.98 ± 1.21 | 2.26 ± 1.77 | 0.280 | 12 | SUVT/B | 5.50 ± 3.95 | 12.76 ± 16.39 | 0.272 |
Amount | 29.90 ± 37.90 | 22.70 ± 40.92 | 0.025 | Amount | 15.00 ± 28.23 | 22.33 ± 36.81 | 0.531 |